Esprit Pharma Grabs Prosed EC Through Metagen Pharmaceuticals Buy
This article was originally published in The Pink Sheet Daily
Executive Summary
Esprit plans to promote Prosed EC with other overactive bladder treatments Proquin XR and Sanctura.
You may also be interested in...
Esprit To Market Estrogen Therapy Estrasorb In 2006
The company gains rights to Novavax' topical estrogen therapy Estrasorb after the failure of Novavax' copromotion deal with King.
Esprit To Market Estrogen Therapy Estrasorb In 2006
The company gains rights to Novavax' topical estrogen therapy Estrasorb after the failure of Novavax' copromotion deal with King.
Esprit Pharma Plans November Launch Of Proquin XR Following Licensing Deal
Esprit’s 100 sales reps will initially target marketing efforts to 8,000 urologist offices, with eventual movement to ob/gyn and family practitioners.